CN Patent

CN101378732A — 用于口腔经粘膜递送的生物粘附药物制剂

Assigned to Talphera Inc · Expires 2009-03-04 · 17y expired

What this patent protects

本发明提供了用于可控制的递送口腔经粘膜药物的制剂。该制剂的特征是水凝胶形成或侵蚀型，其为生物粘附的并提供药物可控的和持续的释放，从而提供增加的生物利用度和效力。

USPTO Abstract

本发明提供了用于可控制的递送口腔经粘膜药物的制剂。该制剂的特征是水凝胶形成或侵蚀型，其为生物粘附的并提供药物可控的和持续的释放，从而提供增加的生物利用度和效力。

Drugs covered by this patent

sufentanil-citrate (SUFENTANIL CITRATE)

Patent Metadata

Patent number: CN101378732A
Jurisdiction: CN
Classification: —
Expires: 2009-03-04
Drug substance claim: No
Drug product claim: No
Assignee: Talphera Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.